It’s estimated that nearly 30 million Americans experience some form of sleep apnea. And for the longest time, a CPAP machine was the only remedy. But a promising new treatment is now available.
The multidisciplinary team at Sarasota Memorial’s new, accredited Sleep Disorder Center provides comprehensive evaluations, at-home or overnight diagnostic sleep studies and individualized treatment plans for a wide range of conditions disrupting essential sleep.
The new KATALYST-AV trial, sponsored by Kardigan, Inc aims to evaluate whether the investigational medication ataciguat can slow the buildup of calcium in the aortic valve in adults with moderate calcific aortic valve stenosis (CAVS).
